Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease. - Wikidata - awgldk - TriplyDB

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

http://www.wikidata.org/entity/Q35045451

about

Novel Insights into the Roles of Rho Kinase in Cancer A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects Albumin-associated free fatty acids induce macropinocytosis in podocytes.Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein.Dosage-dependent role of Rac1 in podocyte injury.Loss of endogenous thymosin β4 accelerates glomerular disease.Novel effective drugs for diabetic kidney disease? or not?Aging and uremia: Is there cellular and molecular crossover?Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.Podocyte-actin dynamics in health and disease.Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.Herbal Prescription, DSGOST, Prevents Cold-Induced RhoA Activation and Endothelin-1 Production in Endothelial Cells.Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1 TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1.MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration.Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.Inhibition of Rac family protein impairs colitis and colitis-associated cancer in mice.Angiotensin II induces reorganization of the actin cytoskeleton and myosin light-chain phosphorylation in podocytes through rho/ROCK-signaling pathway.Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach Rho-GTPase Signalling in the Pathogenesis of Nephrotic Syndrome

P2860

Q26771368-AF10CF25-7AC7-40C2-8CB9-06908ECBF361 Q27309265-82E32DB6-280D-4F43-9792-5E06D95635AB Q35899435-811A94CA-F555-47AB-ADE5-02F77AAD3C2F Q35994961-C3BD13FE-2769-44D2-BC18-0B1E6578C382 Q36727443-95122A46-17FD-4CB6-BF9A-DEE8C071556D Q36810711-CB652A76-732D-4D9C-AF52-ADA0A4019281 Q37354989-9F49F827-78A3-4620-8E28-74A5F576470E Q38265818-C60CD540-3215-4752-B752-1CC73A442AB9 Q38348935-47DE065B-9D6B-44FB-B185-CB2046E15760 Q38770231-09E8D3FE-BF73-4428-9D11-B9FC4A92405F Q38940494-63387D44-601D-481D-B090-B0BD92306DBB Q39096936-77C0CBEC-C9E5-4F06-87B1-4B180211BFBA Q39197971-7C6AE60F-D25E-4BC0-8F56-0A110684883F Q41159058-A456179E-5B15-489F-825A-5D9C1EE2F714 Q42080051-E1C7F4EA-DA81-444C-A3A7-460350B0D665 Q45069613-CAA9C44A-F38F-4338-A5DC-620E8F0C4B07 Q48118712-B0B5AECF-6386-4174-A10D-D2B64F19F167 Q48507180-EC6DC0FA-6F3D-4D85-A4D6-EED6512D294F Q52896749-187875C4-9B76-4817-A2D6-09DB24859629 Q57652246-338B34EC-2E9D-4C8E-9E64-548D8188EDF5 Q59052275-39B7302D-A9B7-40C5-98AC-37829243E963

P2860

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

http://www.wikidata.org/entity/Q35045451

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

@en

type

label

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

@en

prefLabel

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

@en

P1433

Q35045451-35E841AD-4862-482F-B4B4-57EC4FA20B8C

P1476

Q35045451-BD8974D3-3ED2-4A97-9394-A4460A90EDF5

P2093

Q35045451-0EB26CFD-AC92-4ECB-A7DD-5965D958BF74

Q35045451-14446C3D-7F9E-4B7F-A8E7-2ACFFABB2318

Q35045451-40469996-A52D-4228-9559-24BB4F3E68BE

Q35045451-671864E4-1FD1-4D52-821D-59A944B1C215

Q35045451-7ABED4A2-CAC6-4D78-99C2-1B75BB0E7AD1

Q35045451-971D7D9C-5D05-4250-B72F-E774D13A64B5

Q35045451-A99445B8-F9CA-479B-86A8-B85AEF5BE15D

Q35045451-B0791BA5-941C-4A59-9457-C5EBD0449337

Q35045451-B71B0BC4-2A9C-46EB-BAA1-5DC45534F396

Q35045451-EE4BA6AE-1E21-469C-9FDF-0E5763F44E29

P2860

Q35045451-0A2A894E-04BC-48CC-9D1B-3F6A8AB25EBA

Q35045451-11481A34-C9CD-4E97-AB0D-87D234B692E1

Q35045451-11D555A8-30BC-43C9-99D0-991CF3352D40

Q35045451-152912AA-6157-4EE0-8664-5ABEF51E27DF

Q35045451-1B993A1E-A3DD-4F86-90CC-F72177634D16

Q35045451-2317D7DA-D623-40C7-BEBE-CC27760D1C9A

Q35045451-353175F5-C599-42CD-A494-74A2BE7592F4

Q35045451-3E785B97-D751-42A5-AFC9-6402D8B56D49

Q35045451-45B28E56-4EF7-4BCB-9FB5-E5F991465098

Q35045451-472CFF48-8103-43CB-ABC2-96182B577DE5

P304

Q35045451-4111E1BE-C212-4AD6-B950-0E07983BC59D

P31

Q35045451-83DFA558-A70B-42A9-974F-56469C30DC81

P356

Q35045451-5D1E3D91-61E9-43A2-852C-38F3ADF69620

P407

Q35045451-4F671F77-0C44-40E5-9466-9C3C632539C5

P433

Q35045451-1C3CCDD4-6801-4C03-A75A-41FCF6E9DFC4

P478

Q35045451-50692587-3DF9-4636-AFEA-99C57FF7B244

P50

Q35045451-3555A6C1-EBF6-4476-8EE5-97B8EA5EB75E

Q35045451-4AD0FA72-DE1A-4EBC-9E7F-C27738319011

P577

Q35045451-42C546C4-2F7C-4B6A-8028-85D57B3FBDDB

P5875

Q35045451-9BA845E0-7BC3-4F83-96AB-D94383DF2E53

P698

Q35045451-88D72413-7D4E-404E-9765-211D9BAEC599

P932

Q35045451-7A51F112-9EED-44C0-8994-7C50A94CEC8C

P356

JOURNAL.PONE.0080328

P1433

P1476

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

@en

P2093

Andrea Babelova

http://www.w3.org/2001/XMLSchema#string

Christian Fork

http://www.w3.org/2001/XMLSchema#string

Felix Jansen

http://www.w3.org/2001/XMLSchema#string

Hartmut Ruetten

http://www.w3.org/2001/XMLSchema#string

Hermann Pavenstädt

http://www.w3.org/2001/XMLSchema#string

Holger Stark

http://www.w3.org/2001/XMLSchema#string

Kerstin Amann

http://www.w3.org/2001/XMLSchema#string

Kerstin Sander

http://www.w3.org/2001/XMLSchema#string

Liliana Schäfer

http://www.w3.org/2001/XMLSchema#string

Matthias Löhn

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of chronic kidney disease

Cell migration: integrating signals from front to back

RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease

Rho and Rac take center stage

Activation of a local tissue angiotensin system in podocytes by mechanical strain.

Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor.

Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease

Novel aspects of the roles of Rac1 GTPase in the cardiovascular system

Renal basement membrane components.

Modelling the effects of vascular stress in mesangial cells.

P304

e80328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0080328

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ralf P. Brandes

Christoph Daniel

P577

2013-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258639947

http://www.w3.org/2001/XMLSchema#string

P698

24244677

http://www.w3.org/2001/XMLSchema#string

P932

3820652

http://www.w3.org/2001/XMLSchema#string